DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, will host an investor and analyst day on Monday, June 28, from 9:30 a.m. to 12:30 p.m. at the Intercontinental Hotel in Boston, featuring presentations on USpella from leading physicians.
